FDA Inspection 725761 — Shire Human Genetic Therapies Inc

Shire Human Genetic Therapies Inc — FEI 3005955297

The FDA completed an inspection of Shire Human Genetic Therapies Inc on May 19, 2011 in Cambridge, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 19, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cambridge, MA (United States)